iThera Medical GmbH develops and markets a novel in-vivo biomedical imaging technology, Multispectral Optoacoustic Tomography (MSOT). MSOT utilizes the photoacoustic effect to visualize and quantify anatomical, functional and molecular information in living tissue. MSOT allows the early and reliable validation of new substance efficacy in drug discovery (e.g., for oncology, neurology and cardio-vascular problems) and promises to become a valuable tool in clinical diagnostics.
iThera Medical is based in Neuherberg / Munich.
Nanoparticle contrast agents for Photoacoustic Imaging.
Learn more about partnering with NanoHybrids.